Investec PLC (INVP)
London Exchange · UK · prices in GBX · close of 23 Oct 2026
Key indicators
| Last close | GBX 595.50 |
|---|---|
| 52-week range | 499.36 – 690.00 |
| Return, 1 month / 3 months | −6.3% / −3.8% |
| Return, 1 year / 3 years | +2.4% / +30.8% |
| Trend | Below its 200-day average |
| RSI (14) | 41 |
| Volatility (1 year) | 24.0% |
| Worst drawdown (1 year) | -13.7% |
| Average daily value traded | 1,728.06M GBX |
| Dividend yield | 6.5% |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Investec PLC is a specialist banking and asset management group based in London, with a substantial presence in South Africa. It provides private banking, wealth management, corporate and institutional banking, and investment services to private clients, companies and institutions. Its activities include lending, deposits, treasury services and investment management, and it operates across the United Kingdom, South Africa and other international markets.
Investec PLC trades under the code INVP on the London Exchange in UK, with its price quoted in pence sterling (GBX). Our dividend records, which start in 2019, show payments in 8 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Investec PLC (INVP) trades on the London Exchange in UK. It last closed at GBX 595.50 on 23 October 2026.
Its price-based Market X-Ray is 68 out of 100 (a fair price profile), ranking 651 of 3,787 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price rose 2.4% and over the last three months it fell 3.8%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on London Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 52 · Fair | Mixed trend against its averages. | |
| Above 200-day average | -4.3% | ||
| From 52-week high | -12.7% | ||
| Momentum | 46 · Weak | Lagging most stocks on this exchange. | |
| 3-month return | -3.8% | ||
| 6-month return | -6.5% | ||
| 12-month return, skipping the last month | 9.3% | ||
| Stability (higher is calmer) | 83 · Strong | Calmer than most: low volatility and shallow drawdowns. | |
| Volatility, 1 year (lower is calmer) | 24.0% | ||
| Worst drawdown, 1 year (smaller is calmer) | -13.7% | ||
| Liquidity | 98 · Strong | Trades actively. | |
| Average daily value traded | 1,728.06M GBX | ||
| Zero-volume days | 0.0% | ||
| Income | 85 · Strong | Dividend is high and has been paid regularly. | |
| Dividend yield | 6.5% | ||
| Years with dividends | 6 |
Strengths
- Stability (higher is calmer): Calmer than most: low volatility and shallow drawdowns.
- Liquidity: Trades actively.
- Income: Dividend is high and has been paid regularly.
Weak spots
- Momentum: Lagging most stocks on this exchange.
Returns
| 1 week | −1.5% |
|---|---|
| 1 month | −6.3% |
| 3 months | −3.8% |
| 6 months | −6.5% |
| 1 year | +2.4% |
| 3 years | +30.8% |
| 5 years | +96.0% |
Signals
| 50-day / 200-day average | 632.07 / 622.39 |
|---|---|
| Golden / death cross (60 days) | None |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 12.62 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 20 Aug 2026 | GBP 0.2100 |
| 11 Dec 2025 | GBP 0.1750 |
| 14 Aug 2025 | GBP 0.2000 |
| 12 Dec 2024 | GBP 0.1650 |
| 22 Aug 2024 | GBP 0.1900 |
| 7 Dec 2023 | GBP 0.1550 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on London Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.